Paediatrics Publications
Document Type
Article
Publication Date
9-1-2017
Journal
Paediatrics and Child Health (Canada)
Volume
22
Issue
6
First Page
357
Last Page
362
URL with Digital Object Identifier
https://doi.org/10.1093/pch/pxx096
Abstract
Paediatric practitioners interact with industry representatives for many purposes but most often to receive information on new and existing products. While practitioners believe they are immune to the marketing influences exerted by these representatives, research has demonstrated otherwise. The literature suggests that the public is aware of such influences and that most people feel industry influence on practitioners is inappropriate. National guidelines go some way toward regulating practitioner–industry interactions, although they are not always clear or sufficient. The present practice point explores the context for these relationships, raises some ethical issues specific to paediatric practitioners and provides recommendations for maintaining professional integrity in the patient–physician relationship. Paediatric practitioners have a professional duty to ensure that their own interactions with industry are conducted with the best interests of the patient front and centre.
